NVO - ノボ・ノルディスク ()

NVOのニュース

   No­vo Nordisk To Start Phase 3 Obe­si­ty Tri­al With Oral Semaglu­tide  2021/04/21 17:53:05 Benzinga
Novo Nordisk A/S (NYSE: NVO ) is entering the Phase 3a study in obesity with oral semaglutide 50 mg. The decision follows the completion of the STEP phase 3a trial with once-weekly subcutaneously administered semaglutide 2.4 mg. The company will launch the trial in the second half of … Full story available on Benzinga.com
   Novo Nordisk macht das, was Warren Buffett gefällt! Von The Motley Fool  2021/04/13 00:00:00 Investing.com Germany
Novo Nordisk macht das, was Warren Buffett gefällt!
   Marc Andreessen says he found the 'silver bullet' for weight loss, and he's been using the drug for 40 days without side effects  2021/03/26 16:40:14 Business Insider
Summary List Placement Marc Andreessen is trying to eat right in lockdown, just like millions of people around the world. The tech investor says he reads dietary guidance from experts — vegetables, good; vegetable oil , maybe bad — but it's hard keep up. "I'm trying to do my best but then I'm hungry all the time. You know, it's like, f--k. I got to concentrate on my work and I want to spend time with my kids and I don't want to be hungry all the time," Andreessen said on a podcast . Now, the six-foot-five venture capitalist says he's found a "miracle drug" and he sees it as a cure for the obesity epidemic. On the " Lindy Talk " podcast in early March, Andreessen told host Paul Skallas that he had been taking a version of semaglutide, a drug used to treat type 2 diabetes, for about 40 days and that it stopped his hunger pangs. The drug semaglutide was found in one recent study to help people with obesity lose more weight than any other medicine on the market, although it's only approved by regulators for use in adults with type 2 diabetes. "I've been taking this now for like 40 days, and I gotta tell you, it's freaking amazing," Andreessen said on the podcast. "It's just like absolutely amazing.
   Novo Nordisk and TetraScience partner on a cloud-based instrument data platform  2021/03/23 11:50:00 PR Newswire
BAGSVÆRD, Denmark and BOSTON, March 23, 2021 /PRNewswire/ -- Novo Nordisk A/S, a leading global healthcare company, and TetraScience, the leading global Life Sciences R&D Data Cloud, announce a new partnership to design a cloud-based instrument data platform for drug R&D, built natively…
   Reproductive Hormone Market Next Big Thing | Major Giants AbbVie Inc., Allergan plc, Pfizer Inc., Novo Nordisk A/S, Endo Pharmaceuticals Inc  2021/03/23 10:25:38 OpenPR
CMI Published Latest Global Reproductive Hormone Market Study by in-depth analysis about current scenario, the Market size, demand, growth pattern, trends, and forecast. Revenue for Reproductive Hormone Market has grown substantially over the seven years to 2020 as a result
   Novo Nordisk and TetraScience partner on a cloud-based instrument data platform  2021/03/23 11:50:00 PR Newswire
BAGSVÆRD, Denmark and BOSTON, March 23, 2021 /PRNewswire/ -- Novo Nordisk A/S, a leading global healthcare company, and TetraScience, the leading global Life Sciences R&D Data Cloud, announce a new partnership to design a cloud-based instrument data platform for drug R&D, built natively…
   Reproductive Hormone Market Next Big Thing | Major Giants AbbVie Inc., Allergan plc, Pfizer Inc., Novo Nordisk A/S, Endo Pharmaceuticals Inc  2021/03/23 10:25:38 OpenPR
CMI Published Latest Global Reproductive Hormone Market Study by in-depth analysis about current scenario, the Market size, demand, growth pattern, trends, and forecast. Revenue for Reproductive Hormone Market has grown substantially over the seven years to 2020 as a result
   Ildsjælen bag verdens tredjestørste fond takker af med en salut til politikerne: Find flere penge til universiteterne  2021/03/20 17:14:00 Berlingske
Birgitte Nauntofte har i mere end et årti være ildsjælen bag Novo Nordisk Fondens udvikling fra en mindre, ukendt fond til en af verdens største. Fonden uddeler milliarder til dansk forskning og er med til at sikre, at store virksomheder som Novo Nordisk og Novozymes bliver i Danmark. Men hun savner en hjælpende hånd fra politikerne.
   U.S. Safety Needles Market Emerging Growth By Top Players Medtronic Plc., Becton, Dickinson and Company, Boston Scientific Corporation, Smith Medical, Abbott Laboratories, Argon Medical Devices, Inc., Novo Nordisk A/S  2021/03/19 07:51:08 OpenPR
Safety needles are designed for delivering drugs and collecting fluids from the body with safety features to avoid needle stick injuries. There are various types of safety needles such as fine aspirating needles, biopsy needles, hypodermic needles, pen needles, suture
   Therapeutic Proteins and Oral Vaccines Market Emerging Growth By Top Players Abbott Laboratories, Amgen, Inc., Biogen, Inc, Eily, Lilly, and Company, F. Hoffmann-La Roche, Johnson and Johnson, Merck & Co., Novo Nordisk, Pfizer, Inc  2021/03/19 07:44:47 OpenPR
Therapeutic proteins can be used to replace a protein that is abnormal or deficient in a particular disease. They can also augment the body’s supply of a beneficial protein to help reduce the impact of disease or chemotherapy. Genetically engineered
   Novo-boss slingrer i vaccinevalsen med statsministeren – men Mette F. får nok sin vilje  2021/03/17 06:25:00 Berlingske
Vi havde næppe vacciner mod hverken corona, ebola eller kopper, hvis ikke regeringerne i USA og Tyskland havde pumpet milliarder i udvikling og produktion. Et godt gæt er, at Novo Nordisk Fonden leverer en pose penge til en dansk coronasatsning.
   Regeringen drøfter dansk vaccineproduktion med stenrig fond  2021/03/15 09:15:00 Berlingske
Den danske regering er lige nu i dialog om muligheden for at etablere produktion af vacciner på dansk grund med landets største fond, Novo Nordisk Fonden, der råder over en formue på over 400 milliarder kroner. Det oplyser erhvervsministeriet i en mail til Berlingske. Novo Nordisk Fonden bekræfter, at der er »drøftelser med regeringen om mulighederne for at etablere en vaccineproduktion i Danmark«.
   Pen Needles Market Segmentation and Analysis by Recent Trends, Development and Growth by Regions to 2028 | Dickinson and Company, Novo Nordisk, Ulticare, Ypsomed Holding AG, B. Braun Melsungen AG  2021/03/12 15:17:09 OpenPR
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘Pen Needles Market: Global Opportunity Analysis and Industry Forecast 2021-2028’. The Pen Needles Market is expected to witness growth in upcoming years due to factors such as increase in target patient
   Top Insights Of Smart Insulin Pens Market Report Covered By TBRC Market Research With Major Key Players: Eli Lilly and Company, Novo Nordisk A/S  2021/03/11 05:32:18 OpenPR
New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports The global smart insulin pens market is expected to grow from $75.8 million in 2019 and
   Novo-fonden vil gøre dansk landbrug klimasmart  2021/03/04 17:25:00 Berlingske
Novo Nordisk Fonden investerer trecifrede millionbeløb i forskning i klimaløsninger til dansk landbrug. Men det er kun plantedriften, der får glæde af pengene. Fonden har truffet en principbeslutning om ikke at give penge til direkte forskning i kødproduktion.

calendar